US1104481072 - ADR

**BTI** gets a fundamental rating of **6** out of 10. The analysis compared the fundamentals against 10 industry peers in the **Tobacco** industry. While **BTI** belongs to the best of the industry regarding profitability, there are concerns on its financial health. **BTI** may be a bit undervalued, certainly considering the very reasonable score on growth **BTI** also has an excellent dividend rating.

In the past 5 years **BTI** has always been profitable.

Each year in the past 5 years **BTI** had a positive operating cash flow.

With an excellent **Return On Equity** value of **12.12%**, **BTI** belongs to the best of the industry, outperforming **100.00%** of the companies in the same industry.

The **Return On Invested Capital** of **BTI** (**7.34%**) is comparable to the rest of the industry.

The **Average Return On Invested Capital** over the past 3 years for **BTI** is significantly below the industry average of **21.62%**.

The last **Return On Invested Capital** (**7.34%**) for **BTI** is above the 3 year average (**6.40%**), which is a sign of increasing profitability.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 6% | ||

ROE | 12.12% | ||

ROIC | 7.34% |

ROA(3y)4.65%

ROA(5y)4.42%

ROE(3y)9.73%

ROE(5y)9.47%

ROIC(3y)6.4%

ROIC(5y)6.1%

In the last couple of years the **Operating Margin** of **BTI** has grown nicely.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 45.7% | ||

PM (TTM) | 31.06% | ||

GM | 83.54% |

OM growth 3Y3.08%

OM growth 5Y2.97%

PM growth 3Y3.02%

PM growth 5Y-33.94%

GM growth 3Y-0.09%

GM growth 5Y2.15%

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), **BTI** is creating some value.

The number of shares outstanding for **BTI** has been reduced compared to 1 year ago.

Compared to 5 years ago, **BTI** has less shares outstanding

Compared to 1 year ago, **BTI** has an improved debt to assets ratio.

The Debt to FCF ratio of **BTI** is **4.31**, which is a neutral value as it means it would take **BTI**, **4.31** years of fcf income to pay off all of its debts.

Looking at the **Debt to FCF ratio**, with a value of **4.31**, **BTI** is in the better half of the industry, outperforming **80.00%** of the companies in the same industry.

A Debt/Equity ratio of **0.51** indicates that **BTI** is somewhat dependend on debt financing.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.51 | ||

Debt/FCF | 4.31 | ||

Altman-Z | 1.35 |

ROIC/WACC1.11

WACC6.59%

A Current Ratio of **0.93** indicates that **BTI** may have some problems paying its short term obligations.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 0.93 | ||

Quick Ratio | 0.58 |

The **Earnings Per Share** has grown by an nice **12.66%** over the past year.

Looking at the last year, **BTI** shows a small growth in **Revenue**. The Revenue has grown by **7.01%** in the last year.

EPS 1Y (TTM)12.66%

EPS 3Y4.68%

EPS 5Y5.48%

EPS growth Q2Q8.46%

Revenue 1Y (TTM)7.01%

Revenue growth 3Y2.24%

Revenue growth 5Y7.17%

Revenue growth Q2Q4.44%

EPS Next Y3.01%

EPS Next 2Y3.25%

EPS Next 3Y4.46%

EPS Next 5Y9.25%

Revenue Next Year0.27%

Revenue Next 2Y1%

Revenue Next 3Y2.19%

Revenue Next 5Y3.11%

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

The **Price/Earnings** ratio is **5.90**, which indicates a rather cheap valuation of **BTI**.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 5.9 | ||

Fwd PE | 5.75 |

80.00% of the companies in the same industry are more expensive than **BTI**, based on the **Enterprise Value to EBITDA** ratio.

Based on the **Price/Free Cash Flow** ratio, **BTI** is valued cheaper than 90.00% of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 5.2 | ||

EV/EBITDA | 6.67 |

The high **PEG Ratio(NY)**, which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.

The excellent profitability rating of **BTI** may justify a higher PE ratio.

PEG (NY)1.96

PEG (5Y)1.08

EPS Next 2Y3.25%

EPS Next 3Y4.46%

Compared to an average industry **Dividend Yield** of **5.53**, **BTI** pays a better dividend. On top of this **BTI** pays more dividend than 90.00% of the companies listed in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 9.19% |

The dividend of **BTI** has a limited annual growth rate of **5.42%**.

The dividend of **BTI** decreased recently.

Dividend Growth(5Y)5.42%

Div Incr Years1

Div Non Decr Years1

The dividend of **BTI** is growing, but earnings are growing more, so the dividend growth is sustainable.

DP56.1%

EPS Next 2Y3.25%

EPS Next 3Y4.46%

**BRITISH AMERICAN TOB-SP ADR**

NYSE:BTI (12/6/2023, 11:17:07 AM)

**28.745**

**-2.79 (-8.86%) **

Chartmill FA Rating

GICS SectorConsumer Staples

GICS IndustryGroupFood, Beverage & Tobacco

GICS IndustryTobacco

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap64.29B

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 9.19% |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 5.9 | ||

Fwd PE | 5.75 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)1.96

PEG (5Y)1.08

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 6% | ||

ROE | 12.12% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 45.7% | ||

PM (TTM) | 31.06% | ||

GM | 83.54% | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.19

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.51 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 0.93 | ||

Quick Ratio | 0.58 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)12.66%

EPS 3Y4.68%

EPS 5Y

EPS growth Q2Q

EPS Next Y3.01%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)7.01%

Revenue growth 3Y2.24%

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y